Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
RisingPSA: Hormonal Therapy +/- Docetaxel in High-Risk Prostate Cancer with Biochemical Relapse
NCT00764166Phase 3Unknown
- Sponsor
- Assistance publique - Hôpitaux de Paris
- Start
- Jun 2003
- Primary completion
- Nov 2009
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of docetaxel in prostate cancer (PCa), sponsored by Assistance publique - Hôpitaux de Paris. Status: unknown.
02
Drugs
docetaxel
03
Conditions
prostate cancer (PCa)
Beyond the preview
Go deeper on NCT00764166.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00764166.